FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

6 results

cuprimine
(penicillamine)
Bausch Health US, LLC
Usage: CUPRIMINE is indicated for treating Wilson's disease, cystinuria, and severe, active rheumatoid arthritis in patients unresponsive to conventional therapy. It is not effective for ankylosing spondylitis. Treatment aims to reduce copper accumulation in Wilson's disease and urinary cystine levels in cystinuria.
depen
(Penicillamine)
Meda Pharmaceuticals Inc.
Usage: DEPEN is indicated for treating Wilson’s disease, cystinuria, and severe rheumatoid arthritis in patients who have not responded to conventional therapy. It helps minimize copper intake and promotes copper excretion in Wilson’s disease, reduces cystine excretion to prevent stone formation in cystinuria, and assists in managing severe rheumatoid arthritis.
penicillamine
(penicillamine)
Par Pharmaceutical, Inc.
Usage: Penicillamine tablets are indicated for treating Wilson’s disease, cystinuria, and severe rheumatoid arthritis that has not responded to conventional therapies. They aid in reducing copper accumulation in Wilson’s disease and managing cystine excretion in cystinuria, while use in rheumatoid arthritis is limited due to potential severe adverse reactions.
tiopronin
(tiopronin)
Amneal Pharmaceuticals NY LLC
Usage: Tiopronin delayed-release tablets are indicated, along with high fluid intake, alkali, and dietary changes, for preventing cystine stone formation in adults and children aged 9 and older with severe homozygous cystinuria who do not respond to standard treatments.
tiopronin
(Tiopronin)
Biocon Pharma Inc.
Usage: Tiopronin Delayed-Release Tablets are indicated for preventing cystine stone formation in adults and pediatric patients (≥20 kg) with severe homozygous cystinuria, when combined with high fluid intake, alkali, and dietary modifications.
venxxiva
(tiopronin)
Cycle Pharmaceuticals Ltd.
Usage: VENXXIVA is indicated for the prevention of cystine stone formation in adults and pediatric patients aged 9 and older with severe homozygous cystinuria, in combination with high fluid intake, alkali, and dietary modifications, for those not responsive to other measures.

Medications for Cystinuria

cuprimine

depen

penicillamine

tiopronin

tiopronin

venxxiva